¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ghost cell glaucoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • mantle cell lymphoma
    ¿ÜÅõ¼¼Æ÷¸²ÇÁÁ¾
  • marrow cell
    °ñ¼ö¼¼Æ÷
  • mast cell
    ºñ¸¸¼¼Æ÷
  • mast cell degranulation
    ºñ¸¸¼¼Æ÷Å»°ú¸³
  • mast cell disease
    ºñ¸¸¼¼Æ÷º´
  • mastoid air cell
    ²ÀÁö¹úÁý, À¯µ¹¹úÁý
  • matrix cell
    ¹ÙÅÁÁú¼¼Æ÷, ±âÁú¼¼Æ÷
  • memory B cell
    ±â¾ïB¼¼Æ÷
  • memory cell
    ¸é¿ª±â¾ï¼¼Æ÷
  • memory T cell
    ±â¾ïT¼¼Æ÷
  • Merkel cell-neurite complex
    ¸Þ¸£Ä̼¼Æ÷½Å°æµ¹±âº¹ÇÕ, Ã˰¢¼¼Æ÷½Å°æµ¹±âº¹ÇÕü
  • mesangial cell
    Ç÷°ü»çÀ̼¼Æ÷, ¸Þ»êÁö¿ò¼¼Æ÷
  • mesenchymal cell
    Áß°£¿±¼¼Æ÷
  • mesothelial cell
    ÁßÇǼ¼Æ÷
  • microglial cell
    ¹Ì¼¼¾Æ±³¼¼Æ÷, ¼Ò±³¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • polynucleated cell
    ¹µÇÙ¼¼Æ÷
  • prickle cell
    °¡½Ã¼¼Æ÷
  • primed cell
    ÃÊȸ°¨ÀÛ¼¼Æ÷
  • primordial germ cell
    ¿ø½ÃÁ¾ÀÚ¼¼Æ÷
  • principal cell
    ÁÖ¼¼Æ÷
  • Purkinje cell
    ½ÉÀåÀüµµ±ÙÀ°¼¼Æ÷, Á¶·Õ¹Ú¼¼Æ÷
  • pyramidal cell
    ÇǶó¹Ô¼¼Æ÷
  • receptor cell
    ¼ö¿ëü¼¼Æ÷
  • red blood cell
    ÀûÇ÷±¸
  • reserve cell
    ¿¹ºñ¼¼Æ÷
  • residential cell
    Á¤ÁÖ¼¼Æ÷
  • resting cell
    ÈÞÁö±â¼¼Æ÷, Á¤Áö¼¼Æ÷
  • reticular cell
    ±×¹°¼¼Æ÷
  • reticuloendothelial cell
    ±×¹°³»ÇǼ¼Æ÷, ¼¼¸Á³»ÇǼ¼Æ÷
  • reticulum cell
    (¢¡reticular cell) ±×¹°¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • hypoglycemia, beta cell tumor
    ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
  • hypoxic cell
    Àú»ê¼Ò¼¼Æ÷
  • hypoxic cell sensitizer
    Àú»ê¼Ò¼¼Æ÷°¨ÀÛÁ¦
  • i-cell disease
    I-¼¼Æ÷º´
  • idiotype specific regulatory cell
    °³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
  • immortalized cell
    ¹«ÇÑÁõ½Ä¼¼Æ÷
  • immunity,cell-mediated
    ¼¼Æ÷¸Å°³¼º(á¬øàØÚË¿àõ)
  • immunocompetent cell
    ¸é¿ªÀû°Ý¼¼Æ÷.
  • immunodeficiency syndrome, cell mediated
    ¼¼Æ÷¸Å°³ ¸é¿ª°áÇÌ ÁõÈıº
  • immunologically committed cell
    ¸é¿ª°æÇè¼¼Æ÷(¡­ÌèúÐá¬øà).
  • immunologically competent cell
    ¸é¿ªÀû°Ý¼¼Æ÷(¡­îêÌ«á¬øà).
  • immunologically performing cell
    ¸é¿ª¼öÇ༼Æ÷(¡­âÄú¼á¬øà).
  • indeterminate cell
    ºÎÁ¤Çü(ÜôïÒû¡) ¼¼Æ÷(á¬øà)
  • indifferent cell
    ¹«°ü¼¼Æ÷.
  • indirect cell division
    °£Á¢¼¼Æ÷ºÐ¿­.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • cell strain
    ¼¼Æ÷ÁÖ(á¬øàñ»)
  • cell strain
    ¼¼Æ÷ÁÖ
  • cell strain
    ¼¼Æ÷ÁÖ
  • cell strain
    ¼¼Æ÷ÁÖ(á¬øàñ»).
  • cell substitution
    ¼¼Æ÷ġȯ, Ç÷±¸Àç»ý(Ì´Ë´ ?Ë×).
  • cell substitution
    ¼¼Æ÷ġȯ, Ç÷±¸Àç»ý(úìϹ î¢ßæ).
  • cell surface characteristic
    ¼¼Æ÷Ç¥¸éƯ¼º
  • cell surface receptor
    ¼¼Æ÷Ç¥¸é¼ö¿ëü
  • cell survival curve
    ¼¼Æ÷»ýÁ¸°î¼±
  • cell transformation
    ¼¼Æ÷ÇüÁúÀüȯ, ¼¼Æ÷º¯Çü
  • cell typing
    Ç÷±¸Çü°Ë»ç
  • cell wall
    ¼¼Æ÷º®
  • cell wall
    ¼¼Æ÷º®.
  • cell wall antigen
    ¼¼Æ÷º®Ç׿ø
  • cell wall inhibitor
    ¼¼Æ÷º®ÇÕ¼º¾ïÁ¦Á¦
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
MAHA Micro-Angiopathic Hemolytic Anemia; PB»ó Helmet Cell
  ThrombocytopeniaÁß MAHAÀ¯¹ß
&nbs...
MCH Mean Corpuscular(= Cell) Hemoglobin; 26 - 33 pg; Æò±ÕÀûÇ÷±¸ Ç÷»ö¼Ò·®
      ...
MCHC Mean Corpuscular(= Cell) Hemoglobin Concentration; 32 - 36 %; Æò±ÕÀûÇ÷±¸ Ç÷»ö¼Ò³óµµ
   &nbs...
MCV Mean Corpuscular(= Cell) Volume; 80 - 100 fL(= 10-5 L); Æò±ÕÀûÇ÷±¸¿ëÀû
     &n...
PCMV Parietal Cell Mass Vagotomy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
BOSCC Bovine ocular squamous cell carcinoma
BOEC Bovine oviduct epithelial cell
BREC bovine retinal endothelial cell
BCEC brain capillary endothelial cell
BMEC brain microvascular endothelial cell
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • proliferating cell pool

    proliferating pleurisy (Áõ½Ä¼º È丷¿°

  • pyknotic endothelial cell
    ³óÃà ÇÙ ³»ÇÇ ¼¼Æ÷
  • pyramidal cell
    ÇǶó¹Ô ¼¼Æ÷, Ãßü ¼¼Æ÷, ÇǶó¹Ô ¸ð¾ç ¼¼Æ÷
    ºÎ¼öµÈ ¼¶À¯¿Í °°ÀÌ Ãßü ½Å°æ¿øÀ» ±¸¼ºÇϰí ÀÖ´Â ´ë³ú ÇÇÁúÀÇ Å©°í ´Ù±Ø¼ºÀÎ ÃßüÇü ½Å°æÀý ¼¼Æ÷ÀÇ Çϳª.
  • R-S cell
    ¸®µå-½ºÅÙ¹ö±× ¼¼Æ÷
    È£µåŲ½ºº´¿¡¼­ ³ªÅ¸³ª´Â ´ÙÇÙ °Å´ë ¼¼Æ÷.
  • red blood cell
    ÀûÇ÷±¸
    µ¿ÀǾî=erythrocyte. »ê¼Ò³ª ÀÌ»êȭź¼Ò¸¦ ¿î¹ÝÇÏ´Â Ç÷¾× ³»¿¡ Á¸ÀçÇÏ´Â Ç÷±¸.
  • red cell volume
    ÀûÇ÷±¸ ¿ëÀû
    ü³»ÀÇ ÃÑÀûÇ÷±¸ ¿ë·®À¸·Î¼­ ¹æ»ç´É µ¿À§¿ø¼Ò·Î ÃøÁ¤ÇÑ´Ù.
  • Reed-sternberg cell
    ¸®µå-½ºÅϹö±× ¼¼Æ÷
    Hodgkinº´¿¡ Ư¡ÀûÀÎ Ä¿´Ù¶õ ÀÌÇü Á¶Á÷±¸ÀÌ´Ù. ÀüÇüÀûÀÎ ¼¼Æ÷´Â ´ã¿°¼ºÀÇ È£»ê¼º ¼¼Æ÷ÁúÀ» °¡Áö¸ç, 1-2°³ÀÇ ´ëÇü ÇÙ ¶Ç´Â Áö³ªÄ¡°Ô ºÐ¿±ÇÑ ÇÙÀ» °®´Â´Ù. ±× ÇÙÀº º¯¿¬ºÎ¿¡´Â ¿°»öÁúÀÇ µ¢¾î¸®¿Í ºñÁ¤»óÀûÀ¸·Î ÇöÀúÇÑ È£»ê¼ºÀÇ ÇÙ¼Òü¸¦ °¡Áö°í ÀÖ´Ù. ÀÌÇÙ¼ºÀÇ °ÍÀº °¡²û °æ»óÇüÀ» ³ªÅ¸³½´Ù.
  • renal cell carcinoma
    ½Å ¼¼Æ÷ ¾ÏÁ¾
  • renomedullary interstitial cell tomor
    ½Å ¼öÁú °£Áú ¼¼Æ÷Á¾ Á¾¾ç
  • Renshaw cell
    ·»¼î ¼¼Æ÷
    ¿îµ¿¼º ´º·Ð°ú ¾ïÁ¦¼º ¿¬°áÀ» Çϰí ÀÖ´Â Àü°¢ÀÇ º¹Ãø ³»Ãø ¿µ¿ª³»ÀÇ °³Àç ´º·Ð.
  • reserve cell
    ¿¹ºñ ¼¼Æ÷, ÀúÀå ¼¼Æ÷
    ±â°üÁö »óÇÇÀÇ ±âÀú ȤÀº ¹èÃþÀÇ ¼¼Æ÷.
  • residential cell
    Á¤ÁÖ ¼¼Æ÷
  • reticulum cell
    ¼¼¸Á ¼¼Æ÷
  • retinal cell
    ¸Á¸· ¼¼Æ÷
  • rheumatoid arthritis cell
    ·ù¸¶ÅäÀÌµå °üÀý¿° ¼¼Æ÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
cell cycle restriction point <cell biology, molecular biology> A point, late in G1, after which the cell must, normally, proceed through to division at its standard rate.
(26 Mar 1998)
cell death <cell biology> Cells die (nonaccidentally) either when they have completed a fixed number of division cycles (around 60, the Hayflick limit) or at some earlier stage when programmed to do so, as in digit separation in vertebrate limb morphogenesis.
Whether this is due to an accumulation of errors or a programmed limit is unclear, some transformed cells have undoubtedly escaped the limit.
See: apoptosis.
(26 Mar 1998)
cell degranulation The process of losing cytoplasmic granules. This occurs in mast cells, basophils, neutrophils, eosinophils, and platelets when secretory products are released from the granules.
(12 Dec 1998)
cell determination The process by which embryonic cells, previously undifferentiated, take on a specific developmental character.
Although the mechanism is not fully understood, homeotic proteins coded for by certain gene sequences (the homeobox) appear to trigger the process. Genes for homeotic proteins show remarkable similarity among species.
See: morphogenesis, induction, evocator.
(05 Mar 2000)
cell differentiation Progressive restriction of the developmental potential and increasing specialization of function which takes place during the development of the embryo and leads to the formation of specialised cells, tissues, and organs.
(12 Dec 1998)
cell disruption <technique> The procedures used to get genetically engineered products out of the cells in which they are produced.
These procedures may be mechanical, resulting in cell breakage, or depend upon cell lysis, which is caused by adding lysozyme or solvents that affect the cell membrane, or antibiotics or antimetabolites that disrupt or disorganize cell wall growth.
(26 Mar 1998)
cell division The separation of one cell into two daughter cells, involving both nuclear division (mitosis) and subsequent cytoplasmic division (cytokinesis).
(18 Nov 1997)
cell division cycle gene Genes which control the yeast cell cycle. There are around 50 different genes which do this.
(09 Oct 1997)
cell division cycle mutant A yeast cell which has cell division cycle genes that have mutated to become sensitive to temperature, at certain temperatures (usually high ones), various parts of the normal yeast cell cycle become abnormal, and in some strains the yeast cell does not survive at all.
(09 Oct 1997)
cell division phases The stages which a cell undergoes when dividing. There are four successive phases: prophase, metaphase, anaphase, and telephase.
(12 Dec 1998)
cell electrophoresis <technique> A method for estimating the surface charge of a cell by looking at its rate of movement in an electrical field. Almost all eukaryotic cells have a net negative surface charge.
Measurement is complicated by the streaming potential at the wall of the chamber itself and by the fact that the cell is surrounded by a layer of fluid (see double layer).
The electrical potential measured (the zeta potential) is actually some distance away from the plasma membrane. One of the more useful modifications is to systematically vary the pH of the suspension fluid to determine the pK of the charged groups responsible (mostly carboxyl groups of sialic acid).
(26 Mar 1998)
cell extracts Preparations of cell constituents or subcellular materials, isolates, or substances.
(12 Dec 1998)
cell fate <embryology> Of an embryonic parent (progenitor) cell or cell type, the range and distribution of differentiated tissues formed by its daughter cells.
For example: cells of the neural crest differentiate to form among other things) cells of the peripheral nervous system.
(26 Mar 1998)
cell fractionation <technique> Strictly this should mean the separation of homogeneous sets from a heterogeneous population of cells (by a method such as flow cytometry).
The term is more frequently used to mean subcellular fractionation i.e. The separation of different parts of the cell by differential centrifugation, to give nuclear, mitochondrial, microsomal and soluble fractions.
(26 Mar 1998)
cell-free extract <cell culture> A liquid that is a mixture of the contents of a particular type of cell, sometimes the organelles are also filtered out of the liquid.
(26 Mar 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á